Ophthalmic compositions
AssigneeBiotheravision Inc.
InventorsRoland Bodmeier, Chin-Ming Chang
Life of this patent
Estimating the term…
Abstract
The invention provides an aqueous liquid composition for ophthalmic administration, comprising therapeutically effective amounts of a ketorolac compound and of a corticosteroid, wherein the ketorolac compound is present in an essentially dissolved form; wherein the corticosteroid is present in the form of suspended particles; and wherein the composition exhibits an acidic pH of about 6.5 or less. The invention further provides compositions as disclosed herein for use in the prevention or treatment of ocular inflammation and methods for preventing or treating ocular inflammation in a subject.
Claims22
An aqueous liquid composition for ophthalmic administration, comprising therapeutically effective amounts of a ketorolac compound and of a corticosteroid, wherein the ketorolac compound is present in an essentially dissolved form;
- wherein the corticosteroid is present in the form of suspended particles;
- wherein the composition exhibits an acidic pH of about 6.5 or less;
- and wherein the viscosity of the aqueous liquid composition is in the range from about 1 to about 60 centipoise (cps) or millipascal-second (mPa·s).
Dependencies are inferred from the claim text.